Abstract:Abstract An ovalbumin (OVA)-induced allergic rhinitis (AR) mouse model was established to investigate whether quercetin (QUE) treats AR via TLR4/MyD88/IRAK4 signaling pathway. SPF grade Balb/c mice were randomly divided into 4 groups: normal control (NC), OVA, dexamethasone (DEX), and (QUE) groups. OVA and aluminum hydroxide [AL(OH) 3 ] were injected intraperitoneally for basic sensitization and OVA was dripped into the nose for challenge to induce a mouse model of AR. The mice were scored by observing the behaviors of scratching, sneezing and runny nose to assess whether the modeling was successful. The treatment groups (DEX and QUE) were given the corresponding drugs for gavage treatment for 1 week after successful modeling, and the OVA and NC groups were treated with normal saline instead. The levels of OVA-IgE, IL-4, IL-13, IL-1β, IL-17 and IL-10 in serum were measured by enzyme-linked immunosorbent assay (ELISA); the changes of mice nasal mucosa were observed in hematoxylin-eosin (HE) stained histopathological sections; the relative expression levels of mRNA and protein of TLR4, MyD88, IRAK4, NF-κB in lung tissues were measured by quantitative real-time PCR (qPCR) and western blot, respectively; the changes in the percentages of regulatory T cells (Treg) and helper T cells 17 (Th17) in splenocytes were detected by flow cytometry. The results showed that the allergic symptoms scores were greater than 10 points and the expression levels of OVA-IgE, IL-4, IL-13, IL-1β and IL-17 in the serum increased and the expression level of IL-10 decreased in the OVA group compared with NC group. HE staining of the nasal cavity suggested detachment and necrosis of the nasal mucosa, tissue edema, and inflammatory cell infiltration in the OVA group. The relative expression levels of mRNA and protein of TLR4, MyD88, IRAK4, NF-κB in lung tissues were increased and the percentage of Treg cells decreased and the percentage of Th17 cells increased in splenocytes of the OVA group. Based on these results, we speculate that QUE may inhibit inflammatory responses and induce immune tolerance via TLR4/MyD88/IRAK4 signaling pathway in mice model of AR.

An Antagonist for CCR4 Alleviates Murine Allergic Rhinitis by Intranasal Administration

A New Antagonist for CCR4 Attenuates Allergic Lung Inflammation in a Mouse Model of Asthma

Alleviation of Murine Allergic Rhinitis by C19, a C-terminal Peptide of Chemokine-Like Factor 1 (CKLF1)

Assessment of Tumor Growth Factor-Β1 Neutralizing Antibody in the Treatment of Allergic Rhinitis and Asthma.

The study of the role of purified anti-mouse CD193 (CCR3) antibody in allergic rhinitis mouse animal models

Inhibition of TRPA1 Reduces Airway Inflammation and Hyperresponsiveness in Mice with Allergic Rhinitis.

Allosteric inhibition of CXCR1 and CXCR2 abrogates Th2/Th17-associated Allergic Lung Inflammation in Mice

A Synthetic Toll-Like Receptor 2 Ligand Decreases Allergic Immune Responses in a Mouse Rhinitis Model Sensitized to Mite Allergen

Experimental observation of the effect of immunotherapy on CD4+ T cells and Th1/Th2 cytokines in mice with allergic rhinitis

CCR3 Monoclonal Antibody Inhibits Airway Eosinophilic Inflammation and Mucus Overproduction in a Mouse Model of Asthma

2-Aminoethoxydiphenyl Borate Administration into the Nostril Alleviates Murine Allergic Rhinitis

Lactoferrin Administration Into The Nostril Alleviates Murine Allergic Rhinitis And Its Mechanisms

In Vivo Intranasal Anti-Cd23 Treatment Inhibits Allergic Responses in a Murine Model of Allergic Rhinitis.

Human C-C Chemokine Receptor 3 Monoclonal Antibody Inhibits Pulmonary Inflammation in Allergic Mice

A New Antagonist For Ccr4 Attenuates Allergic Lung Inflammation In A Mouse Model Of Asthma (Vol 7, 15038, 2017)

CCR3 gene knockout inhibits proliferation, differentiation, and migration of eosinophils in allergic rhinitis model mice

TLR4 antagonist ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing inflammatory monocytes infiltration in mice model

Antagonism of m3 Alleviates Type 2 Inflammation in Allergic Rhinitis Mice.

CCR3 gene knockout in bone marrow cells ameliorates combined allergic rhinitis and asthma syndrome (CARAS) by reducing airway inflammatory cell infiltration and Th2 cytokines expression in mice model

The role and mechanism of quercetin via TLR4/MyD88/IRAK4 signaling pathway in the treatment of allergic rhinitis

Intranasal administration of ceramide liposome suppresses allergic rhinitis by targeting CD300f in murine models